Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel H S Silverman

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 7, 2005
Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDGWei Chen, Timothy Cloughesy, Nirav Kamdar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 6, 2005
Optimizing imaging protocols for overweight and obese patients: a lutetium orthosilicate PET/CT studyBenjamin S Halpern, Magnus Dahlbom, Martin A Auerbach, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2007
Biodistribution and predictive value of 18F-fluorocyclophosphamide in mice bearing human breast cancer xenograftsAmanda L Kesner, Wei-Ann Hsueh, Nwe Linn Htet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2014
Cognitive function after the initiation of adjuvant endocrine therapy in early-stage breast cancer: an observational cohort studyPatricia A Ganz, Laura Petersen, Steven A Castellon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18F] fluorothymidine positron emission tomography: a pilot studyWei Chen, Sibylle Delaloye, Daniel H S Silverman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 5, 2006
Semiautomated analysis of small-animal PET dataAdam L Kesner, Magnus Dahlbom, Sung-Cheng Huang, et al.
Molecular Imaging and Biology|December 20, 2005
Usefulness of 3'-[F-18]fluoro-3'-deoxythymidine with positron emission tomography in predicting breast cancer response to therapyBetty S Pio, Cecilia K Park, Richard Pietras, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 19, 2002
Evaluating early dementia with and without assessment of regional cerebral metabolism by PET: a comparison of predicted costs and benefitsDaniel H S Silverman, Sanjiv S Gambhir, Hsuan-Wen C Huang, et al.
Molecular Imaging and Biology|September 23, 2003
Noninvasive quantification of bowel inflammation through positron emission tomography imaging of 2-deoxy-2-[18F]fluoro-D-glucose-labeled white blood cellsBetty S Pio, Fergus R Byrne, Richard Aranda, et al.
Breast Cancer Research and Treatment|September 30, 2006
Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapyDaniel H S Silverman, Christine J Dy, Steven A Castellon, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 7, 2005
Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDGWei Chen, Timothy Cloughesy, Nirav Kamdar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 6, 2005
Optimizing imaging protocols for overweight and obese patients: a lutetium orthosilicate PET/CT studyBenjamin S Halpern, Magnus Dahlbom, Martin A Auerbach, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2007
Biodistribution and predictive value of 18F-fluorocyclophosphamide in mice bearing human breast cancer xenograftsAmanda L Kesner, Wei-Ann Hsueh, Nwe Linn Htet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2014
Cognitive function after the initiation of adjuvant endocrine therapy in early-stage breast cancer: an observational cohort studyPatricia A Ganz, Laura Petersen, Steven A Castellon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18F] fluorothymidine positron emission tomography: a pilot studyWei Chen, Sibylle Delaloye, Daniel H S Silverman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 5, 2006
Semiautomated analysis of small-animal PET dataAdam L Kesner, Magnus Dahlbom, Sung-Cheng Huang, et al.
Molecular Imaging and Biology|December 20, 2005
Usefulness of 3'-[F-18]fluoro-3'-deoxythymidine with positron emission tomography in predicting breast cancer response to therapyBetty S Pio, Cecilia K Park, Richard Pietras, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 19, 2002
Evaluating early dementia with and without assessment of regional cerebral metabolism by PET: a comparison of predicted costs and benefitsDaniel H S Silverman, Sanjiv S Gambhir, Hsuan-Wen C Huang, et al.
Molecular Imaging and Biology|September 23, 2003
Noninvasive quantification of bowel inflammation through positron emission tomography imaging of 2-deoxy-2-[18F]fluoro-D-glucose-labeled white blood cellsBetty S Pio, Fergus R Byrne, Richard Aranda, et al.
Breast Cancer Research and Treatment|September 30, 2006
Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapyDaniel H S Silverman, Christine J Dy, Steven A Castellon, et al.
Pageof 6